Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
2
×
boston blog main
boston top stories
deals
life sciences
national blog main
atrial fibrillation
biontech
biotech
boehringer ingelheim
boston scientific
clinical trial
cryterion medical
curevac
eli lilly
fda
food and drug administration
infectious diseases
investing
john shiver
medical devices
mergers & acquisitions
millipede
moderna therapeutics
mrna
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
securus medical group
startups
translate bio
vaccines
What
deal
2
×
time
2
×
acquire
adding
atrial
bets
bio
boston
business
cancer
comes
companies
continues
cryterion
cut
date
device
effective
enticed
evidence
fibrillation
hasn’t
heart
latest
management
medicines
messenger
molecules
mrna
multiple
new
pharmaceutical
primarily
promise
proven
rhythm
rna
sanofi
scientific
second
Language
Current search:
boston
×
deal
×
time
×
@xconomy.com
5 years ago
Boston Scientific Continues M&A Streak with $202M Deal for Cryterion
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
